How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bio-Organic Herbicide Market
- By Formulation Type: Liquid, Granular, Wettable Powder, Emulsifiable Concentrate, Dust
- By Mode of Application: Foliar Spray, Soil Treatment, Seed Treatment, Pre-emergence Application, Post-emergence Application
- By Active Ingredient Type: Plant Extracts (e.g., essential oils), Microbial Agents (e.g., Bacillus subtilis), Fatty Acids (e.g., pelargonic acid), Organic Acids (e.g., acetic acid), Natural Enzymes
- By Crop Type: Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Turf & Ornamentals, Plantation Crops
- By Target Weed Type: Broadleaf Weeds, Grassy Weeds, Sedge Weeds, Perennial Weeds
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Liquid leads By Formulation Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Bio-Organic Herbicide Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Formulation Type 5
Mode of Application 5
Active Ingredient Type 5
Crop Type 5
Target Weed Type 4
Companies profiled
BASF SE
Bayer AG
Syngenta AG
Nufarm Limited
UPL Limited
Arysta LifeScience Corporation
Valent BioSciences LLC
Certis USA LLC
Marrone Bio Innovations Inc.
Valent U.S.A. LLC
Tessenderlo Group
Bioworks Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →UPL Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Arysta LifeScience Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Valent BioSciences LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Certis USA LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Marrone Bio Innovations Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Valent U.S.A. LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Tessenderlo Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bioworks Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Isagro S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Koppert Biological Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Andermatt Biocontrol AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$7,357M by 2033 · 3.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Liquid52.5
- Granular12.2
- Wettable Powder8.8
- Emulsifiable Concentrate12.6
- Dust13.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,799M → $2,413M · 3.7%
Europe$1,254M → $1,731M · 4.1%
Asia Pacific$1,145M → $1,549M · 3.9%
Latin America$708.5M → $857.9M · 2.4%
Middle East and Africa$545.0M → $762.0M · 4.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.772026
3.782027
3.792028
3.812029
3.822030
3.832031
3.842032
3.862033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE22.7
- Bayer AG20.6
- Syngenta AG7.5
- Nufarm Limited7.1
- UPL Limited3.9
- Arysta LifeScience Corporation10.1
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Formulation Type27.8%
Mode of Application11.9%
Active Ingredient Type14.7%
Crop Type20.4%
Target Weed Type25.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.0
- Europe23.7
- Asia Pacific21.2
- Latin America11.7
- Middle East and Africa10.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 86 | 98 | 77 | 90 | 78 | 92 | 87 |
| Bayer AG | 92 | 91 | 89 | 83 | 91 | 75 | 87 |
| Syngenta AG | 70 | 85 | 72 | 71 | 81 | 84 | 77 |
| Nufarm Limited | 74 | 79 | 81 | 80 | 68 | 71 | 76 |
| UPL Limited | 66 | 55 | 74 | 77 | 52 | 68 | 65 |
| Arysta LifeScience Corporation | 61 | 48 | 71 | 66 | 57 | 69 | 62 |
| Valent BioSciences LLC | 63 | 57 | 48 | 45 | 46 | 55 | 52 |
| Certis USA LLC | 57 | 39 | 55 | 54 | 44 | 59 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Bayer AG
- Syngenta AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Bayer AG | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Syngenta AG | ✓ | ✓ | − | ◐ | ✓ | ✓ |
| Nufarm Limited | − | ✓ | ✓ | ◐ | ✓ | ✓ |
| UPL Limited | ✓ | ◐ | ◐ | ✓ | − | ◐ |
| Arysta LifeScience Corporation | − | ◐ | − | − | − | ◐ |
| Valent BioSciences LLC | ◐ | − | − | ◐ | − | − |
| Certis USA LLC | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE87
2Bayer AG87
3Syngenta AG77
4Nufarm Limited76
5UPL Limited65
6Arysta LifeScience Corporation62
7Valent BioSciences LLC52
8Certis USA LLC51
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SEBayer AG
Challenger2
Strong scale, closing on the leaders.
Syngenta AGNufarm Limited
Contender2
Focused players with pockets of strength.
UPL LimitedArysta LifeScience Corporation
Niche2
Specialists in a single segment or region.
Valent BioSciences LLCCertis USA LLC
Go-to-market strategy
Land Formulation Type in North America, then scale across Bio-Organic Herbicide Market — a $614M beachhead inside a $9.23B market.
Beachhead (SOM)$614Mobtainable near-term
Serviceable (SAM)$3.65Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Liquid
Best fit — highest urgency & budget in Formulation Type.
Economic buyer80 fit
Granular
Strong fit — clear ROI and a fast path to value.
End user67 fit
Wettable Powder
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Formulation Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Mode of Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Active Ingredient Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel27%
Digital / self-serve23%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Formulation Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bio-Organic Herbicide Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified25%
Evaluation13%
Closed-won7%
$12.4KCAC
$60KLTV
4.8:1LTV : CAC
< 5 moCAC payback
Investment thesis
Bio-Organic Herbicide Market is a durable-growth opportunity — $5.11B by 2033, compounding at 6.6%.
TAM · 2025$3.06Btoday
TAM · 2033$5.11Bforecast
CAGR6.6%2027–2033
Cumulative$36.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.11BTotal addressable market
SAM$1.79BServiceable available market
SOM$328MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.6% CAGR
Demand compounds through 2033, outpacing GDP across Formulation Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Formulation Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.11BLarge & growingTAM by 2033 at 6.6% CAGR
$1.79BServiceable nowreachable with today’s model
$328MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.98BBear4.3% CAGR
$5.11BBase6.6% CAGR
$6.54BBull8.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Mode of Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bio-Organic Herbicide Market — a $7.78B market by 2033. Plan: grow share from 8.4% to 18.5%.
Market size · 2033$7.78Btotal addressable
Market CAGR8.5%2027–2033
Target share18.5%from 8.4% today
Revenue ambition$1.44Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.4% | 18.5% | Ahead |
| Revenue | $622M | $1.44B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 36.5% | 40.3% | At risk |
| Customer retention | 85.3% | 94.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Formulation Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Mode of Application capability
A defensible second engine — invest in Mode of Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Formulation Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Mode of Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $204M capacity & capability investment
- Greenlight bolt-on M&A in Mode of Application
- Authorise North America expansion plan
- Fund R&D program for Formulation Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAhead
Sales deck · value proposition
Win the Bio-Organic Herbicide Market conversation — a $6.44B market you can size, segment and defend in minutes.
Market size · 2033$6.44Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,427+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Formulation Type
Goal Grow share in Formulation Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 4 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SEBayer AGSyngenta AGNufarm LimitedUPL LimitedArysta LifeScience CorporationValent BioSciences LLCCertis USA LLC+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bio-Organic Herbicide Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bio-Organic Herbicide Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →bio-PE Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBiopesticide Preparations Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportBiopesticides, Biofertilizers and Biostimulants Agricultural Biologicals Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBiopharma Product Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBiopharmaceutical Cmo Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBiopharmaceutical Contract Manufacturings Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBiopharmaceutical Third Party Logistics (3PL) Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBiophilic Acoustic Product Market
Market size, share, segmentation and regional forecast.
$759M market · 2025 base year
View reportBiophotonic Imaging Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiophotonic Sensors Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBio-plastic Material Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportBio-Poly Alpha Olefin (PAO) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.